SYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma
Clinical trial NCT04762160 · TERMINATED
Trial details
- NCT number
- NCT04762160
- Sponsor
- Epizyme, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2022-03-22
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.